News Archive

2019

October

Media Release / Oct 01, 2019

Novartis Entresto receives FDA approval for pediatric heart failure, helping to address critical unmet need for treatment options

Read More

September

Novartis scientist talks to woman on the street.
Story / Sep 30, 2019

Word on the Street: What is cell and gene therapy?

We leave the lab to find out what people know about cell and gene therapy.

Read More
Featured News / Sep 24, 2019

Form 483 posting by US Food and Drug Administration (FDA) – Novartis statement

Read More
Media Release / Sep 19, 2019

AveXis presents new data at EPNS continuing to show significant therapeutic benefit of Zolgensma® in prolonging event-free survival now up to 5 years of age in patients with spinal muscular atrophy (SMA) Type 1

Read More
Media Release / Sep 16, 2019

Initiation of Novartis Entresto in-hospital included in the new ACC Expert Consensus Decision Pathway developed to improve management of hospitalized heart failure patients

Read More
Media Release / Sep 02, 2019

Entresto improved measures of heart structure and function in HFrEF patients in new Novartis study; additional data complement findings

Read More
2018

July

Featured News / Jul 16, 2018

Novartis Pharmaceuticals Corporation (Novartis) Statement on Recall Outside the United States of Sandoz Generic Valsartan and Sandoz Valsartan and Hydrochlorothiazide Film-Coated Tablets

Read More

April

Story / Apr 06, 2018

The McCourty Twins & Friends Shine a Spotlight on Sickle Cell Disease

Read More
2013

July

External Link / Jul 02, 2013

Novartis enters the list of the 50 preferred employers among European Engineering/IT students

June

External Link / Jun 14, 2013

New healthcare problems are on the rise, though old issues still exist. How can we improve healthcare in Africa?

Related Links